Is Nassa Labs Methandienone 10mg suitable as a primary oral for a lean-mass bulking cycle?

Yes — Methandienone is one of the few oral anabolic agents validated in nitrogen-balance research specifically for mass-accumulation phases. Its rapid onset of positive nitrogen retention, documented within 48–72 hours of first administration, makes it the standard oral anchor in bulk-oriented cycle architecture. The 10mg tablet denomination from Nassa Labs allows incremental dose progression throughout the bulk without relying on tablet splitting.

What daily dose range is typically used during a bulking cycle with Methandienone 10mg tablets?

Bulk-phase protocols most commonly run 15–30mg per day, structured as a graduated entry at 15–20mg in weeks one and two, with upward adjustment to 25–30mg in weeks three and four contingent on ALT/AST blood-work results. Doses above 30mg per day show disproportionate hepatic enzyme elevation relative to incremental nitrogen-retention gain, making the 15–30mg corridor the evidence-supported bulking range for the majority of practitioners.

Which injectable compounds pair most effectively with Methandienone during a bulk phase?

Long-ester testosterone compounds — Testosterone Enanthate and Testosterone Cypionate — are the most established injectable pairings for a Methandienone-anchored bulk, with the oral driving early nitrogen retention while the ester reaches pharmacokinetic steady-state by weeks three to five. Nandrolone Decanoate is a secondary option frequently incorporated to extend anabolic stimulus through a mechanistically distinct progestin-pathway contribution orthogonal to the oral's androgen-receptor activity.

How many days does a 100-tablet Nassa Labs Methandienone pack last at standard bulking doses?

At 20mg per day, the 100-tablet pack provides exactly 50 days of supply — sufficient for a full six-week bulk-phase insertion with a one-week taper. At 25mg per day it covers 40 days, and at 30mg per day it covers 33 days, aligning with a standard four-to-five-week oral window. The 10mg denomination means every protocol tier runs on whole tablets with no fractional dosing approximations.

Can Nassa Labs Methandienone 10mg tablets be split to achieve sub-10mg doses during a bulk?

Tablet splitting is not recommended as a bulking-cycle practice because compressed-tablet API distribution is not uniform across a tablet face, meaning a split half does not reliably deliver exactly 5mg. Nassa Labs' HPLC content-uniformity verification certifies the whole tablet as the minimum accurate unit. Practitioners requiring doses below 10mg for any reason should use complete cessation between administrations rather than fractional tablets to preserve dose accuracy. (2) angle_used

Pro Choice

Nassa Labs

Methandienone 10mg/tab 100 Tabletten by Nassa Labs

Name: Methandienone 10mg/tab 100 Tablets by Nassa Labs
Brand: Nassa Labs
SKU: ORA-METH-NAS-018
Price: 26.00 EUR
Availability: InStock

Nassa Labs Methandienone 10mg is an oral anabolic tablet formulated specifically to anchor the growth phase of structured bulking cycles, delivering 100 precisely dosed 10mg tablets per pack. Each tablet supplies Methandienone — the 17α-methylated androgen responsible for rapid lean-mass accumulation — at a concentration calibrated for progressive dose building during caloric surplus phases. Tablet excipient composition and API content are verified by HPLC content-uniformity testing; every production batch earns a lot-specific certificate before release.

€26.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Rapid nitrogen-retention onset — measurable positive balance within 48–72 hours supports early bulk-phase weight progression.
Whole-tablet 10mg increments allow a calibrated dose ladder from entry tier to peak bulking dose without cutting tablets.
100-tablet pack volume covers a complete four-to-six-week bulk insertion at the most commonly used daily amounts.
HPLC per-tablet content uniformity confirms that each tablet delivers its declared 10mg, eliminating inter-tablet variance during the bulk.
17α-methylation provides the oral bioavailability required for consistent androgen-receptor activation across the growth phase.
Compatible with established long-ester injectable compounds, forming a mechanistically layered bulking stack.
LAL endotoxin screening on each batch reflects a quality benchmark that exceeds standard oral tablet release requirements.

Phase	Duration	Daily Dose	Note
Entry / Response Assessment	Weeks 1–2	15–20mg	Establish individual hepatic tolerance; obtain baseline ALT/AST before cycle start.
Main Bulk Accumulation	Weeks 3–4	20–30mg	Increase only if mid-cycle blood work shows ALT/AST below 2× upper reference range.
Maintenance / Taper	Weeks 5–6	10–20mg	Step down to the entry dose to reduce hepatic load while injectable compounds sustain anabolic output.
Post-Oral PCT Preparation	After final tablet	0mg Methandienone	Begin SERM-based PCT timing based on the clearance of the longest-acting injectable in the stack.

Key takeaways

Anchor your bulk cycle with Methandienone for nitrogen retention from day two.
Progress from 15mg to 30mg per day based on monitored liver enzyme data.
Pair with long-ester testosterone injectables for sustained mass-phase output.
Select whole-tablet 10mg increments; avoid splitting for accurate bulk dosing.
Limit oral insertion to four–six weeks to protect hepatic enzyme thresholds.

Methandienone as the Cornerstone Oral in Structured Bulking Cycles

Methandienone 10mg by Nassa Labs is a periodised bulking tool: an oral anabolic agent whose primary clinical role across decades of applied pharmacology is accelerating nitrogen retention and lean-tissue accumulation during caloric surplus phases of a structured mass cycle. Unlike compounds repositioned from other applications, Methandienone was purpose-developed — and has been validated in research using urinary nitrogen-balance methodology — for exactly this growth-phase context. Nassa Labs packages 100 tablets at 10mg each, providing a tablet count that maps cleanly to multiple standard bulking-cycle durations without forcing fractional dosing.

How Methandienone Drives Bulk-Phase Muscle Accumulation

Methandienone increases intramuscular nitrogen retention within 48–72 hours of the first administration, as documented in nitrogen-balance assays, giving the bulking practitioner measurable anabolic output from the opening days of a cycle. The androgen-receptor-mediated upregulation of anabolic gene transcription — including IGF-1 and follistatin pathways — produces a sustained positive nitrogen balance that translates into scale-weight progression consistent with lean-tissue accrual when caloric intake supports it. Compared to non-alkylated orals such as DHEA derivatives, Methandienone's 17α-methyl modification confers the hepatic resistance necessary for meaningful oral bioavailability, making it the dominant oral choice in evidence-informed bulking protocol design.

Dosing Architecture for a Bulk-Phase Cycle

Bulk-phase Methandienone protocols structure the oral within a four-to-six-week insertion window, a timeframe consistently cited in applied pharmacology literature as the period before hepatic enzyme elevation begins to outpace incremental nitrogen-retention benefit. A starting tier of 15–20mg per day allows individual response characterisation, with practitioners in the intermediate-to-advanced category progressing to 25–30mg per day in weeks three and four based on ALT/AST monitoring data. The 100-tablet Nassa Labs pack accommodates a 20mg/day protocol for 50 days, a 25mg/day protocol for 40 days, or a stepped structure combining a lower entry dose with a higher maintenance tier — all without tablet splitting.

Quality Infrastructure Supporting Bulk-Cycle Reliability

Nassa Labs subjects each Methandienone production batch to HPLC-based per-tablet content-uniformity testing; the declared 10mg API content must fall within a validated variance band before any batch proceeds to packaging. LAL (Limulus Amebocyte Lysate) endotoxin screening, standard within the Nassa Labs release protocol, ensures that excipient and filler materials meet parenteral-grade reference thresholds even in oral tablet form — a specification that exceeds the minimum required for non-injectable products and reflects the manufacturer's cross-format quality commitment.

Usage

Establish a caloric surplus appropriate for lean-mass accumulation — minimum 300–500kcal above total daily energy expenditure — before initiating the Methandienone bulk-cycle protocol, as anabolic signal without adequate substrate produces limited mass outcomes.
Obtain baseline blood work covering ALT, AST, total testosterone, LH, FSH, haematocrit, and lipid panel; record these reference values before taking the first tablet to enable meaningful mid-cycle and post-cycle comparison.
Begin at 15mg per day (one and a half 10mg tablets split into two administrations with meals) during weeks one and two to characterise individual hepatic and androgenic response before considering dose escalation.
If mid-cycle blood work at week two confirms ALT/AST remain below 2× upper reference range, advance to 20–30mg per day in whole-tablet increments for the main bulk accumulation phase in weeks three and four.
Administer each daily Methandienone portion with food to support gastric tolerability and moderate absorption variability; distribute across two administrations spaced evenly across the waking day.
Taper to the entry dose in the final one to two weeks of the oral window, then discontinue Methandienone entirely while allowing the injectable compounds in the stack to continue carrying the anabolic load through the remainder of the bulk cycle.

Warnings

Contraindications: Methandienone is contraindicated in individuals with pre-existing hepatic disease, elevated baseline liver enzymes (ALT or AST above the upper reference range before cycle start), prostate pathology, history of androgen-sensitive malignancy, or active cardiovascular disease. Women should not use this compound due to its high virilisation potential at any dose used in bulking contexts.

Side Effects: Aromatisation to estradiol produces water retention and gynecomastia risk at bulk-phase doses; androgenic effects include acne, scalp-hair thinning, and — in women — virilisation. Endogenous testosterone suppression is significant; expect measurable LH and FSH suppression within the first two weeks of use. 17α-alkylation produces dose-dependent hepatocellular enzyme elevation (ALT, AST) in the majority of users.

Monitoring: Blood work at cycle entry (baseline), at the mid-point of the oral window (week three), and within two weeks of completing the Methandienone phase is the minimum responsible monitoring schedule. Track ALT, AST, GGT, haematocrit, lipid panel, and total/free testosterone. Discontinue immediately if ALT or AST exceeds 3× upper reference range.

PCT: Post-cycle therapy timing is governed by the clearance of the longest-acting injectable compound in the bulk stack, not by Methandienone's own clearance window. SERM-based recovery using Tamoxifen or Clomiphene forms the pharmacological core; begin no later than two weeks after the final long-ester injection. Hepatoprotective supplementation (TUDCA or UDCA) during the oral phase is standard practice.

Frequently asked questions

Is Nassa Labs Methandienone 10mg suitable as a primary oral for a lean-mass bulking cycle?: Yes — Methandienone is one of the few oral anabolic agents validated in nitrogen-balance research specifically for mass-accumulation phases. Its rapid onset of positive nitrogen retention, documented within 48–72 hours of first administration, makes it the standard oral anchor in bulk-oriented cycle architecture. The 10mg tablet denomination from Nassa Labs allows incremental dose progression throughout the bulk without relying on tablet splitting.
What daily dose range is typically used during a bulking cycle with Methandienone 10mg tablets?: Bulk-phase protocols most commonly run 15–30mg per day, structured as a graduated entry at 15–20mg in weeks one and two, with upward adjustment to 25–30mg in weeks three and four contingent on ALT/AST blood-work results. Doses above 30mg per day show disproportionate hepatic enzyme elevation relative to incremental nitrogen-retention gain, making the 15–30mg corridor the evidence-supported bulking range for the majority of practitioners.
Which injectable compounds pair most effectively with Methandienone during a bulk phase?: Long-ester testosterone compounds — Testosterone Enanthate and Testosterone Cypionate — are the most established injectable pairings for a Methandienone-anchored bulk, with the oral driving early nitrogen retention while the ester reaches pharmacokinetic steady-state by weeks three to five. Nandrolone Decanoate is a secondary option frequently incorporated to extend anabolic stimulus through a mechanistically distinct progestin-pathway contribution orthogonal to the oral's androgen-receptor activity.
How many days does a 100-tablet Nassa Labs Methandienone pack last at standard bulking doses?: At 20mg per day, the 100-tablet pack provides exactly 50 days of supply — sufficient for a full six-week bulk-phase insertion with a one-week taper. At 25mg per day it covers 40 days, and at 30mg per day it covers 33 days, aligning with a standard four-to-five-week oral window. The 10mg denomination means every protocol tier runs on whole tablets with no fractional dosing approximations.
Can Nassa Labs Methandienone 10mg tablets be split to achieve sub-10mg doses during a bulk?: Tablet splitting is not recommended as a bulking-cycle practice because compressed-tablet API distribution is not uniform across a tablet face, meaning a split half does not reliably deliver exactly 5mg. Nassa Labs' HPLC content-uniformity verification certifies the whole tablet as the minimum accurate unit. Practitioners requiring doses below 10mg for any reason should use complete cessation between administrations rather than fractional tablets to preserve dose accuracy. (2) angle_used

Manufacturer

Nassa Labs' formulation decisions for its oral tablet range reflect a specification philosophy that treats excipient selection as analytically accountable rather than incidental. For the Methandienone 10mg tablet, the binder and filler matrix — comprising microcrystalline cellulose and standard pharmaceutical-grade compressible excipients — was chosen to achieve consistent tablet hardness and disintegration profile across the production run, not solely to meet minimum compressibility targets. This matters in a bulking-cycle context because erratic disintegration timing introduces absorption variability that can compromise dose-to-dose consistency across a multi-week protocol. Nassa Labs validates the excipient matrix through dissolution testing aligned with pharmacopoeial standards, generating data confirming that API release profile is reproducible across tablets from the same batch and across separately manufactured batches. The HPLC content-uniformity certificate issued for each Methandienone 10mg batch covers individual tablet API content — not bulk blend — confirming that the excipient-to-API ratio is controlled at the per-unit level where it directly affects each administration.

Product details

Brand	Nassa Labs
Active ingredient	methandienone
Also known as	Dianabol, Methandrostenolon, D-Bol, Danabol, Methandienone, Nassa Labs Dianabol
Strength	10 mg
Form	Tabletten
Pack size	100 pieces
Item number	ORA-METH-NAS-018

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Danabol 10mg/tab 100 Tablets by Balkan Pharmaceuticals

Lab Tested

Danabol 10mg/tab 100 Tabletten by Balkan Pharmaceuticals

Danabol by Balkan Pharmaceuticals is an oral anabolic-androgenic steroid whose active compound, Methandienone (10 mg per tablet), functions as a modified testosterone derivative engineered to bind directly and with notable affinity to the androgen receptor (AR), driving rapid anabolic signalling at the genomic level. Its 17α-alkylated, 2,17-dimethyl structural scaffold distinguishes it from unmodified androgens by increasing receptor-interaction duration and conferring oral bioavailability. Quality assurance for every batch is anchored in two validated analytical checkpoints: HPLC quantification of active-ingredient potency and LAL endotoxin screening — performed under Balkan Pharmaceuticals' certified GMP framework.

€26.00

Pro-Dynabol 20mg/tab 50 Tablets by Beligas Pharmaceuticals

HPLC Verified

Pro-Dynabol 20mg/tab 50 Tabletten by Beligas Pharmaceuticals

Pro-Dynabol is an oral anabolic tablet delivering Methandienone at 20 mg per unit, distinguished by a rapid-absorption, short-duration pharmacokinetic profile that demands a structured intraday dosing schedule to maintain stable plasma concentrations. Each pack contains 50 tablets, providing a complete supply for a standard introductory or intermediate oral cycle. Batch-level potency is confirmed through HPLC analysis; every lot produced by Beligas Pharmaceuticals passes documented laboratory verification before release.

€35.00

Danabol 10mg/tab 100 Tablets by Body Research

Pharma Grade

Danabol 10mg/tab 100 Tabletten by Body Research

Body Research Danabol delivers Methandienone at 10 mg per tablet across a 100-tablet supply, specifically formulated to maximize the oral bioavailability that distinguishes tablet-based administration from injectable Methandienone variants. Oral Methandienone reaches systemic circulation through hepatic first-pass metabolism, which reduces its absolute bioavailability to roughly 50–72 % compared to the near-complete uptake seen with intramuscular injection — a pharmacological trade-off that makes tablet selection, dosing timing, and gastrointestinal conditions decisive factors. Quality is verified through independent HPLC-based potency assay and LAL endotoxin testing; every production batch released under WHO-aligned GMP protocols reflects Body Research's Pharma Grade standard.

€85.00

Anabol Tablets 5mg/tab 1000 Tablets by British Dispensary

Purity Tested

Anabol Tablets 5mg/tab 1000 Tabletten by British Dispensary

British Dispensary Anabol Tablets deliver Methandienone at a precision-dosed 5 mg per tablet — a low-unit format that makes incremental metabolic titration straightforward for experienced users tracking blood-glucose and nutrient-partitioning responses. Anabolic-androgenic activity from this compound is closely linked to shifts in glucose uptake, glycogen synthesis, and overall substrate utilisation, making metabolic monitoring an integral part of any responsible protocol. Quality assurance is built into every 1,000-tablet jar: HPLC-verified potency and LAL endotoxin testing are completed prior to release, with manufacturing conducted under GMP-certified conditions at British Dispensary's Thailand facility.

€85.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00